Goldberg Mark Alan
SEC CIK 1532475 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CBIO | CRESCENT BIOPHARMA, INC. | Dir | 24.8K | — | — | 3 | 2023-09-30 | 2024-03-29 |
Most active insiders at CBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Harwin Peter Evan | Dir, 10% | $18.24M | — |
| 2 | Fairmount Funds Management LLC | Dir, 10% | $12.38M | — |
| 3 | Brumm Joshua T | CEO, Dir | — | $920.8K |
| 4 | McNeill Jonathan | Pres, COO | — | $446.9K |
| 5 | Pinkas Jan | CSO | — | $34.9K |
| 6 | Im Ellie Eunkyung | Chief Medical Off | — | $33.1K |
| 7 | Bispham Barbara Harlin | See Remarks | — | $33.0K |
| 8 | Scalzo Richard William | CFO | — | $30.2K |
| 9 | Lynch Ryan | See Remarks | — | $12.7K |
| 10 | Doughty Christopher Grant | Chief Business Off | — | — |
Goldberg Mark Alan made no open-market trades at CBIO in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | 2024-03-29 | CBIO | CRESCENT BIOPHARMA, INC. | Goldberg Mark Alan | Dir | A - Grant | $3.00 | +4,584 | 24.8K | +23% | +$13.8K | |
| 2024-01-02 | 2023-12-29 | CBIO | CRESCENT BIOPHARMA, INC. | Goldberg Mark Alan | Dir | A - Grant | $2.36 | +5,827 | 20.2K | +40% | +$13.8K | |
| 2023-10-03 | 2023-09-30 | CBIO | CRESCENT BIOPHARMA, INC. | Goldberg Mark Alan | Dir | A - Grant | $1.50 | +9,167 | 14.4K | +175% | +$13.8K |
Purchase Sale Sale after option exercise All abbreviations